Lurasidone Hydrochloride

Preferred Label : Lurasidone Hydrochloride;

MeSH definition : A thiazole derivative and atypical ANTIPSYCHOTIC AGENT that functions as a DOPAMINE D2 RECEPTOR ANTAGONIST; SEROTONIN 5-HT2 RECEPTOR ANTAGONIST, serotonin 5-HT7 receptor antagonist, and antagonist of the adrenergic α2A and α2C receptors, as well as a partial SEROTONIN 5-HT1A RECEPTOR AGONIST. It is used in the treatment of SCHIZOPHRENIA and BIPOLAR DISORDER.;

MeSH synonym : Hydrochloride, Lurasidone; Lurasidone HCl; HCl, Lurasidone;

MeSH Hyperonym : lurasidone; N-(2-(4-(1,2-benzisothiazol-3-yl)-1-piperazinylmethyl)-1-cyclohexylmethyl)-2,3-bicyclo(2.2.1)heptanedicarboximide;

MeSH hyponym : SM 13496; Latuda; 13496, SM; SM13496; SM-13,496; SM 13,496; SM13,496; SM-13496;

MeSH Related Number : 22IC88528T; 367514-87-2 (lurasidone); 367514-88-3 (lurasidone hydrochloride);

Is substance : O;

UNII : O0P4I5851I;

Details

Origin ID

D000069056;

UMLS CUI

C2697950;

ATC code(s)
- lurasidone [ATC Code]
Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analogs and derivatives [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Automatic exact mappings (from CISMeF team)
- Lurasidone [LOINC component]
- Lurasidone [ICD-11 Extension code]
- Product containing lurasidone (medicinal product) [SNOMED CT concept]
- lurasidone [ATC Code]
CISMeF manual mappings
- Lurasidone Hydrochloride [NCIt concept]
- Lurasidone hydrochloride (substance) [SNOMED CT concept]
Pharmacological action(s)
- Dopamine D2 Receptor Antagonists [MeSH Descriptor]
- adrenergic alpha-2 receptor antagonists [MeSH Descriptor]
- antipsychotic agents [MeSH Descriptor]
- central nervous system depressants [MeSH Descriptor]
- psychotropic drugs [MeSH Descriptor]
- serotonin 5-HT2 receptor antagonists [MeSH Descriptor]
Record concept(s)
- Latuda [MeSH concept]
- Lurasidone Hydrochloride [MeSH concept]
- SM 13496 [MeSH concept]
- lurasidone [MeSH concept]
See also inter- (CISMeF)
- Lurasidone Measurement [NCIt concept]
Semantic type(s)
- Organic Chemical [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- Lurasidone Hydrochloride [NCIt concept]
- Lurasidone hydrochloride (substance) [SNOMED CT concept]
Validated automatic mappings to NTBT
- Lurasidone [NCIt concept]
- Lurasidone (substance) [SNOMED CT concept]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients